◀ Back to NOS1

NOS1 — ZGLP1

Text-mined interactions from Literome

Salehi et al., PloS one 2008 (Diabetes Mellitus, Experimental...) : The incretin hormone GLP-1 , which is used in clinical practice suppressed iNOS and ncNOS expression and activity with almost full restoration of insulin release and partial restoration of glucagon release
Chai et al., Diabetes 2012 : After confirming that GLP-1 potently stimulates nitric oxide ( NO ) synthase ( NOS ) phosphorylation in endothelial cells, overnight fasted adult male rats received continuous GLP-1 infusion ( 30 pmol/kg/min ) for 2 h plus or minus NOS inhibition
Zheng et al., Cardiovascular diabetology 2013 (Diabetes Mellitus, Type 2) : Twenty-four weeks of acarbose monotherapy in newly diagnosed patients with T2D is associated with significantly increased levels of both fasting and postprandial GLP-1 as well as significantly increased NO levels and NOS activity for those patients in whom postprandial GLP-1 levels were increased